Indian Velpatasvir Exporters: Complete Supplier Ranking with Market Share — 103 Manufacturers (2026) — TransData Nexus

Q: Who is the largest velpatasvir supplier from India?

MYLAN LABORATORIES LIMITED is the largest velpatasvir exporter from India with a 49.6% market share and export value of $12.2M.

Q: How many velpatasvir suppliers are there in India?

There are 103 active velpatasvir exporters in India, collectively shipping $24.7M worth of velpatasvir across 671 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top velpatasvir suppliers from India?

The top 5 velpatasvir suppliers from India — MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, EURO LIFECARE PRIVATE LIMITED, NATCO PHARMA LIMITED, KARDI TRADING PRIVATE LIMITED — together control 92.8% of total velpatasvir export value from India.

Suresh Sormare

Velpatasvir

India Pharmaceutical Trade Intelligence

$24.7M103 Suppliers95 CountriesHS 30049099

ExportsIndia → VIETNAM19.1%India → LATVIA14.9%

ImportsUNITED STATES → India$206.1K GERMANY → India$43.1K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: SIA "MAGNIPHARMA",

Velpatasvir Suppliers from India (2026) — 103 Exporters, $24.7M Market | TransData Nexus | TransData Nexus

Who Exports Velpatasvir from India — 103 Suppliers Behind a $24.7M Market

India's velpatasvir export market is supplied by 103 active exporters who collectively shipped $24.7M across 671 shipments. MYLAN LABORATORIES LIMITED leads with a 49.6% market share, followed by HETERO LABS LIMITED and EURO LIFECARE PRIVATE LIMITED. The top 5 suppliers together control 92.8% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Velpatasvir Suppliers & Exporters — 103 manufacturers, $24.7M export market, top destinations and formulations — Velpatasvir supplier data — 103 exporters · $24.7M market · 671 shipmentsTransData Nexus · Indian Customs Data

Top Velpatasvir Exporters from India — Ranked by Export Value

MYLAN LABORATORIES LIMITED is the leading velpatasvir exporter from India, holding a 49.6% share of the $24.7M market across 671 shipments from 103 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, EURO LIFECARE PRIVATE LIMITED, NATCO PHARMA LIMITED, KARDI TRADING PRIVATE LIMITED — collectively control 92.8% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (49.6%), HETERO LABS LIMITED (21.0%), EURO LIFECARE PRIVATE LIMITED (15.7%), NATCO PHARMA LIMITED (5.2%), KARDI TRADING PRIVATE LIMITED (1.3%).

Top Velpatasvir Exporters from India

Ranked by export value · 103 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Velpatasvir Exporters from India — Ranked by Export Value. 103 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Velpatasvir exporters

Certification and compliance status for top Velpatasvir suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
MYLAN LABORATORIES LIMITED	Approved	Yes, as of April 202	Yes	Not verified	FDA-approved; WHO-GMP certified in April 2025; EU-GMP compliant.
HETERO LABS LIMITED	Approved	Yes, as of September	Yes	Not verified	FDA-approved; WHO-GMP certified in September 2025; EU-GMP compliant.
NATCO PHARMA LIMITED	Approved	Yes, as of November	Yes	Not verified	FDA-approved; WHO-GMP certified in November 2025; EU-GMP compliant.

TransData Nexus reviewed the regulatory standing of 3 leading Velpatasvir exporters from India. 3 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 3 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Velpatasvir sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of active pharmaceutical ingredients (APIs). The city hosts numerous manufacturers specializing in APIs, contributing significantly to India's pharmaceutical exports. Companies like Manus Aktteva Biopharma LLP, based in Hyderabad, supply Velpatasvir APIs to both domestic and international markets.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to leading companies such as Alembic Pharmaceuticals, Zydus Lifesciences, and Torrent Pharmaceuticals, which are involved in the development and manufacturing of finished dosage forms. These companies have a strong presence in both domestic and international markets, contributing to the export of formulations containing Velpatasvir.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for pharmaceuticals. This region houses major pharmaceutical companies like Sun Pharmaceutical Industries Limited, which manufacture and export a wide range of pharmaceutical products, including those containing Velpatasvir. The strategic location and well-established infrastructure facilitate efficient distribution to international markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Velpatasvir exporters from India

November 2025

M&A

Natco Pharma Limited — Natco Pharma acquires 35.75% stake in Adcock Ingram

In November 2025, Natco Pharma completed the acquisition of a 35.75% stake in Adcock Ingram, a South African pharmaceutical company, for approximately US$226 million. This acquisition led to the delisting of Adcock Ingram from the Johannesburg Stock Exchange. - IMPACT: This strategic move is expected to enhance Natco Pharma's global footprint, potentially increasing Velpatasvir exports to the African market.

Impact: This strategic move is expected to enhance Natco Pharma's global footprint, potentially increasing Velpatasvir exports to the African market.

December 2024

Regulatory

Hetero Labs Limited — Hetero Labs receives FDA approval for new Velpatasvir formulation

In December 2024, Hetero Labs Limited received approval from the U.S. Food and Drug Administration (FDA) for a new formulation of Velpatasvir, enhancing its therapeutic efficacy. - IMPACT: This approval is anticipated to boost Hetero Labs' Velpatasvir production and export capabilities, particularly to the U.S. market.

Impact: This approval is anticipated to boost Hetero Labs' Velpatasvir production and export capabilities, particularly to the U.S. market.

Common Questions — Velpatasvir Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which velpatasvir supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 63 recorded shipments worth $12.2M. HETERO LABS LIMITED (74 shipments) and EURO LIFECARE PRIVATE LIMITED (7 shipments) are also established high-volume exporters.

Q How many velpatasvir manufacturers are there in India?

India has 103 active velpatasvir exporters with a combined export market of $24.7M across 671 shipments to 95 countries. The top 5 suppliers hold 92.8% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for velpatasvir from India?

Average FOB unit price: $88.44 per unit, ranging from $0.94 to $6479.33. Average shipment value: $36.7K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Velpatasvir

Velpatasvir

Who Exports Velpatasvir from India — 103 Suppliers Behind a $24.7M Market

Top Velpatasvir Exporters from India — Ranked by Export Value

Top Velpatasvir Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Natco Pharma Limited — Natco Pharma acquires 35.75% stake in Adcock Ingram

Hetero Labs Limited — Hetero Labs receives FDA approval for new Velpatasvir formulation

Common Questions — Velpatasvir Suppliers from India

Q Which velpatasvir supplier from India is the most reliable for bulk orders?

Q How many velpatasvir manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for velpatasvir from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Mylan Laboratories Limited — Mylan partners with Gilead Sciences for Velpatasvir distribution

Analysis Methodology